Literature DB >> 11835879

[Etiology of hemoptysis: Prospective analysis of 752 cases].

M Haro Estarriol1, M Vizcaya Sánchez, J Jiménez López, A Tornero Molina.   

Abstract

OBJECTIVES: To know the etiology of hemoptysis and its distribution in our area compared with other current and historic series.
METHODS: Prospective, descriptive study of 752 cases of hemoptysis. The etiology of these cases was determined by evaluating the clinical record, chest X-ray, functional respiratory tests and sputum smear for acid-fast bacilli, together with other examinations such as bronchoscopy and computerized tomography (CT) according to previously established criteria.
RESULTS: The mean age of patients was 60 years (SD: 15 years), 79% were males and 75% smokers. Diagnoses included neoplasms (28%), chronic bronchitis (19.8%), bronchiectasis (14.5%), pneumonia or lung abscess (11.5%), idiopathic forms (8%), and miscellaneous causes with lower percentages such as tuberculosis (1.7%) and its sequelae (4%), cardiac diseases (1.5%) and pulmonary embolism (2.3%). Bronchoscopy was performed in 694 (92.2%) and detected the bleeding site or provided a specific diagnosis in 39% (81% if only neoplasms are considered) and non-specific but abnormal in 57%. The amount of bleeding was small in most cases and kept no relationship with causes.
CONCLUSIONS: Neoplasms, chronic bronchitis and bronchiectasis are the most common causes of hemoptisis in our area. Bronchiectasis and tuberculosis have decreased compared with previous series used as reference. In contrast, there has been an increase in the number of neoplasms and chronic bronchitis and a plateau in those attributed to cardiac diseases, pneumonia or lung abscess and cryptogenetic forms. To obtain the origin, bronchoscopy complemented by CT remains essential.

Entities:  

Mesh:

Year:  2001        PMID: 11835879     DOI: 10.1016/s0014-2565(01)70953-8

Source DB:  PubMed          Journal:  Rev Clin Esp        ISSN: 0014-2565            Impact factor:   1.556


  4 in total

Review 1.  Antifibrinolytic therapy to reduce haemoptysis from any cause.

Authors:  Gabriela Prutsky; Juan Pablo Domecq; Carlos A Salazar; Roberto Accinelli
Journal:  Cochrane Database Syst Rev       Date:  2016-11-02

Review 2.  Approach to Hemoptysis in the Modern Era.

Authors:  Sébastien Gagnon; Nicholas Quigley; Hervé Dutau; Antoine Delage; Marc Fortin
Journal:  Can Respir J       Date:  2017-12-21       Impact factor: 2.409

3.  Hemoptysis with no malignancy suspected on computed tomography rarely requires bronchoscopy.

Authors:  Christian Lund Petersen; Ulla Møller Weinreich
Journal:  Eur Clin Respir J       Date:  2020-02-06

4.  Is investigation of patients with haemoptysis and normal chest radiograph justified?

Authors:  M Thirumaran; R Sundar; I M Sutcliffe; D C Currie
Journal:  Thorax       Date:  2009-05-19       Impact factor: 9.139

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.